Vijay

#IntegratedCare #AdvancedPractice #Asthma #COPD #Bronchiectasis #Oxygen #NIV #BreathingDysfunction #Leadership #Research #RespEd |Views my own|

[James D Chalmers @ProfJDChalmers]

The first approved treatment for bronchiectasis ever in the UK. MHRA approved brensocatib for bronchiectasis patients aged 12 and over
https://t.co/hTvrBUdJqP

[Prof Kamlesh Khunti @kamleshkhunti]

🚑 Those presenting with breathlessness in ED are high-risk.
Long-term risk is striking

📊 18,900+ hospitalised patients, PARADISE cohort

⚠️ In-hospital mortality: 12%

📉 5-yr mortality after discharge:
• 75% acute HF
• 66% respiratory infection
• 62% COPD

🏥 Care in specialised wards reduced in-hospital mortality across all causes and improved long-term survival in HF & RI.

🔑 So Dyspnoea isn’t a symptom, it’s a prognosis.
We need dedicated in-hospital and post-discharge pathways.

#EmergencyMedicine #HeartFailure #Respiratory #PatientPathways

https://t.co/hj8dR4FZdO

[Imperial NHS 💙 @ImperialNHS]

A large NHS study published in @TheLancet has found that a new AI-enabled stethoscope designed to detect serious heart conditions spots them faster and more frequently in primary care. Read our news story. ➡️ https://t.co/wetAh8hh7F

@ImperialNHLI | @ImperialBRC

[NICE @NICEComms]

Thousands of people with COPD are set to benefit from a new targeted treatment that can be taken at home.

Learn more about dupilumab:
https://t.co/VBFGvvh6Wg

[ERS publications @ERSpublications]

European Respiratory Journal: This study shows objective evidence of the adverse physiological, imaging and molecular changes in cannabis smoke-exposed small airways that may contribute to long-term respiratory morbidity https://t.co/LeEFwaaEm2

[NHS England @NHSEngland]

Thank you to all our incredible NHS staff working over the Christmas period 💙

From nurses, doctors and midwives to paramedics, pharmacists and porters, thank you for continuing to care for our loved ones each and every day.

[Chartered Society of Physiotherapy (CSP) @thecsp]

Major breakthrough on safe staffing levels for AHPs

‘Your action helped make this happen, now your evidence can help ensure the final guidance truly reflects the needs of physiotherapy and wider AHP services.’

https://t.co/8ocYaYD1w6

[Chartered Society of Physiotherapy (CSP) @thecsp]

A simple twist left Rajinder crawling in pain.

He thought that was the rest of his life, until physio changed everything.

Lina’s tailored exercise plan got him back to work and back on his feet.

'I don't know where I'd be without it'.

#RightToRehab #PhysioGivesBack

[Chartered Society of Physiotherapy (CSP) @thecsp]

'It’s shocking that rehabilitation space continues to be sidelined and routinely taken away from physiotherapy teams.' @SHazzard

The Guardian reports on our latest survey, which revealed the extent of the loss of rehabilitation space.

#RightToRehab
https://t.co/4pdUo0JuyW

[NEJM @NEJM]

Original Article: Hypertonic Saline or Carbocisteine in Bronchiectasis (CLEAR trial) https://t.co/FleRvkTPUf

Editorial: Time to Reconsider Mucoactive Agents for Airway Clearance https://t.co/r5hozIXKw9

#ERSCongress | @EuroRespSoc

[JAMA Network Open @JAMANetworkOpen]

RCT: #Pulmonary rehabilitation using minimal equipment was noninferior to rehabilitation with specialist gym equipment in improving exercise capacity, dyspnea, and quality of life. https://t.co/lEiV8bhMow

[Paul Pfeffer @DoctorPfeff]

@ImogenSkene And to provide patient-friendly education on why we might advise changes to inhaled therapy. @NHSBartsHealth @NELHCP https://t.co/WnvJY0cQnB

[Paul Pfeffer @DoctorPfeff]

Clear association between frequent SABA use and acute cardiovascular events in both patients with asthma/COPD and those without. Salbutamol is not a benign medication that can be taken excessively without any risks. https://t.co/ey4KoFKDpc

[ThoraxBMJ @ThoraxBMJ]

Optimised oxygenation improves functional capacity during daily activities in patients with COPD on long-term oxygen therapy: a randomised crossover trial
https://t.co/e04KwLfWZS

[ERS publications @ERSpublications]

ERJ Open Research: Chronic refractory cough is common. A virtual, group-based approach that delivers cough suppression therapy was associated with improvements in cough severity visual analogue scale and Leicester cough questionnaire scores. https://t.co/pXamgzKltc

[NIH @NIH]

News: NIH study links particulate air pollution to increased mutations in lung cancers among nonsmokers https://t.co/sQXYgeCQDP

[Chartered Society of Physiotherapy (CSP) @thecsp]

National media coverage as we raise the alarm about the impact of NHS recruitment freezes.

Just 20 posts for newly qualified physiotherapists as 3,000 qualify | via @Independent

https://t.co/BNZ1h4WDTm

[Asthma + Lung UK Research @aluk_research]

New research from Dr Robert Maidstone @OfficialUoM supported by @asthmalunguk has found that women who work night shifts are more likely to suffer with moderate or severe asthma compared to women who work in the daytime. https://t.co/9BiH1yaOVw

[Surya P Bhatt, MD, MSPH @suryapbhatt]

1/2 New pub in @JAMA_current from #CLAIR! New Diagnostic Schema for #COPD 15.4%⬆️COPD among smokers; 6.4%⬇️ diagnosis among airflow obstruction but no symptoms/imaging findings. Newly detected have high risk of mortality, exacerbations and FEV1 decline https://t.co/p0CE6rgaYk

[ATS AII @ATS_AII]

Based on the results of the MATINEE, METREX, AND METREO studies, mepolizumab is now FDA approved for patients with COPD and eosinophilia! An exciting new development in the world of COPD.
#COPD #eosinophils